# BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
> **ANDA211170** · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2020-06-16
## Drug
- **FDA Application Number:** ANDA211170
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
- **Generic name:** BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE,
- **Active ingredients:** BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HIBROW HLTHCARE
- **Manufacturer:** Eywa Pharma Inc
- **First approval:** 2020-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211170)
---
*AI Analytics · CC0 1.0*